Skip to main content
Latest News
March 31, 2026
Bristol Myers Squibb Evolves and Expands Standing in the Gaap to Advance More Equitable Care in Multiple Myeloma as Program Marks Ten Years
March 29, 2026
Bristol Myers Squibb Presents Positive Results from Phase 3 SCOUT-HCM Trial Demonstrating Efficacy and Safety of Camzyos (mavacamten) in Adolescents with Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM)
March 28, 2026
Open Label Outpatient Switch Study Demonstrates Symptom Stability During Transition from Oral Atypical Antipsychotics to Cobenfy™ (xanomeline and trospium chloride)
Latest Events
Event year list
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
October 29, 2026
08:00 AM ET
Bristol Myers Squibb Q3 2026 Results Conference Call
July 30, 2026
08:00 AM ET
Bristol Myers Squibb Q2 2026 Results Conference Call
April 30, 2026
08:00 AM ET
Bristol Myers Squibb Q1 2026 Results Conference Call
Webcast
(opens in new window)
Preliminary Q1 2026 Acquired IPRD & Licensing Income (PDF)